GILMAN STEVEN C
SEC insider (Form 3/4/5 filer). CIK 0001379970. Director at SCYNEXIS INC (SCYX) and 2 other issuers. 10 reported Form 4/5 transactions since Sep 2024; latest on Jun 26, 2025. Located in CAMBRIDGE, MA.
Companies GILMAN STEVEN C has filed insider reports for
- SCYNEXIS INC (SCYX): Director
- Akebia Therapeutics, Inc. (AKBA): Director
- Vericel Corp (VCEL): Director
GILMAN STEVEN C
CIK: 0001379970
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)4 (40.0%)
Position reduction
Option Exercises (M)4 (40.0%)
Derivative conversions
Awards (A)2 (20.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 26, 2025SCYX
SCYNEXIS INC
AwardDirect23K shares- - Jun 10, 2025AKBA
Akebia Therapeutics, Inc.
AwardDirect35.7K shares- - Oct 16, 2024VCEL
Vericel Corp
SaleDirect5.8K shares at avg. $41.36$241K - Oct 16, 2024VCEL
Vericel Corp
ExerciseDirect5.8K shares at avg. $13.05$76K - Oct 2, 2024VCEL
Vericel Corp
ExerciseDirect5.8K shares at avg. $13.05$76K - Oct 2, 2024VCEL
Vericel Corp
SaleDirect5.8K shares at avg. $40.35$235K - Sep 18, 2024VCEL
Vericel Corp
SaleDirect5.8K shares at avg. $45.54$266K - Sep 18, 2024VCEL
Vericel Corp
ExerciseDirect5.8K shares at avg. $13.05$76K - Sep 4, 2024VCEL
Vericel Corp
ExerciseDirect5K shares at avg. $3.74$19K - Sep 4, 2024VCEL
Vericel Corp
SaleDirect5K shares at avg. $48.58$243K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 26, 2025 |  SCYX SCYNEXIS INC | Award | 23,000 | - | - | Direct |
| Jun 10, 2025 |  AKBA Akebia Therapeutics, Inc. | Award | 35,700 | - | - | Direct |
| Oct 16, 2024 |  VCEL Vericel Corp | Sale | 5,833 | $41.36 | $241,253 | Direct |
| Oct 16, 2024 | VCEL Vericel Corp | Exercise | 5,833 | $13.05 | $76,121 | Direct |
| Oct 2, 2024 | VCEL Vericel Corp | Exercise | 5,833 | $13.05 | $76,121 | Direct |
| Oct 2, 2024 | VCEL Vericel Corp | Sale | 5,833 | $40.35 | $235,362 | Direct |
| Sep 18, 2024 | VCEL Vericel Corp | Sale | 5,834 | $45.54 | $265,680 | Direct |
| Sep 18, 2024 | VCEL Vericel Corp | Exercise | 5,834 | $13.05 | $76,134 | Direct |
| Sep 4, 2024 | VCEL Vericel Corp | Exercise | 5,000 | $3.74 | $18,700 | Direct |
| Sep 4, 2024 | VCEL Vericel Corp | Sale | 5,000 | $48.58 | $242,900 | Direct |
1-10 of 10 transactions